chr11-63079948-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001136506.2(SLC22A24):āc.1651C>Gā(p.Gln551Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000253 in 1,543,300 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001136506.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC22A24 | NM_001136506.2 | c.1651C>G | p.Gln551Glu | missense_variant | 10/10 | ENST00000612278.4 | NP_001129978.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC22A24 | ENST00000612278.4 | c.1651C>G | p.Gln551Glu | missense_variant | 10/10 | 5 | NM_001136506.2 | ENSP00000480336 | P4 | |
SLC22A24 | ENST00000417740.5 | c.1648C>G | p.Gln550Glu | missense_variant | 10/10 | 5 | ENSP00000396586 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152160Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000325 AC: 5AN: 153802Hom.: 1 AF XY: 0.0000245 AC XY: 2AN XY: 81590
GnomAD4 exome AF: 0.0000266 AC: 37AN: 1391022Hom.: 1 Cov.: 27 AF XY: 0.0000306 AC XY: 21AN XY: 686610
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2022 | The c.1651C>G (p.Q551E) alteration is located in exon 10 (coding exon 10) of the SLC22A24 gene. This alteration results from a C to G substitution at nucleotide position 1651, causing the glutamine (Q) at amino acid position 551 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at